Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
VHI
Valhi
VHI
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Segments
By product
See full
Titanium Dioxide
90%
0.0%
Land Sales
10%
0.0%
By segment
See full
Component Products
26%
+23.8%
Other financials
Income statement
See full
Revenue
$560.1M
+4.0%
Gross profit
$103.0M
-15.9%
Net income
$2.0M
-88.2%
EPS (diluted)
$0.07
-88.1%
Balance sheet
See full
Cash & equivalents
$193.7M
-0.4%
Total debt
$629.3M
+2.9%
Total equity
$1.0B
-3.5%
Total assets
$2.6B
-5.3%
Cash flow
See full
Operating cash flow
-$46.1M
+70.4%
CapEx
$10.6M
-17.2%
Free cash flow
-$56.7M
+66.4%
Valuation
See full
Market cap
$375.29M
-15.1%
Enterprise value
$810.89M
-5.6%
P/S
0.2×
0.0×
Profitability
See full
Gross margin
13.1%
-8.7pp
Net margin
-3.5%
-9.0pp
FCF margin
12.9%
—
Returns & leverage
See full
Return on equity
-6.9%
-18.7pp
Debt / equity
0.6×
0.0×
Current ratio
3.2×
+0.6×